Abstracts Archive - Page 905 of 1683 - ATC Abstracts

2018 American Transplant Congress
Infectious Complications Associated with Eculizumab Used for ABO-Incompatible Renal Transplantation
M. Campara, P. West-Thielke, K. Progar, N. Jasiak, A. Lichvar, I. Tang, E. Benedetti.
University of Illinois at Chicago, Chicago.
Introduction: A novel approach in ABO-incompatible (ABOi) living donor renal transplant (LDRT) includes use of eculizumab (ECU) that allows for avoidance of traditional desensitization. We…
2018 American Transplant Congress
Latent Tuberculosis Diagnosis Prior to Kidney Transplantation in a High Burden Country: Improvement with Serological Tests
V. Garcia, G. Meinerz, C. da Silva, E. Keitel.
Nephrology and Kidney Transplant Department, ISCMPA, Porto Alegre, Brazil.
Introduction: Diagnosing and treating tuberculosis after kidney transplantation is challenging, and mortality is high. In an epidemiological study performed at our Center, there was an…
2018 American Transplant Congress
Use of Granulocyte Colony-Stimulating Factor for Leukopenia Post-Renal Transplant
S. Hamel,¹ V. Kuo,² D. Johnson,¹ R. Bloom,³ D. Sawinski,³ J. Trofe-Clark.^1,3
¹Pharmacy, Hosp of Univ. of Pennsylvania, Philadelphia; ²Pharmacy, Univ. of California San Francisco, San Francisco; ³Renal Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia.
Purpose: Leukopenia is a frequent complication in renal transplant recipients (RTRs). Granulocyte colony-stimulating factor (G-CSF) accelerates white blood cell (WBC) count recovery; but, published experience…
2018 American Transplant Congress
Ten Years of Low-Dose Valganciclovir; Evaluating the Incidence and Risk Factors of CMV in Kidney Transplant Recipients
S. El Hajj, J. Azzi, M. Kim, S. Gabardi.
Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates; Kidney Transplant, Brigham and Women's Hospital, Boston; Kidney Transplant, Brigham and Women's Hospital, Boston.
Introduction: Cytomegalovirus (CMV) remains one the most clinically relevant and frequent post-transplant infections. Despite the availability of effective antiviral drugs, CMV continues to be of…
2018 American Transplant Congress
Oral Vancomycin Monotherapy versus Combination Therapy in Solid Organ Transplant Recipients with Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study
G. Korayem,^1,2,4 K. Eljaaly,^2,3 K. Matthias,^2,4 T. Zangeneh.^4,5
¹Department of Pharmaceutical Practices, Princess Nourah Bint Abdulrahman University, Riyadh, NA, Saudi Arabia; ²Department of Pharmacy Practice and Science, University of Arizona, Tucson, AZ; ³Department of Clinical Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ⁴Banner - University Medical Center Tucson, Tucson, AZ; ⁵Division of Infectious Diseases, Department of Medicine, University of Arizona, Tucson, AZ.
Introduction:Solid organ transplant (SOT) recipients are at high risk of Clostridium difficile infection (CDI) and CDI recurrence. A combination of metronidazole and oral vancomycin is…
2018 American Transplant Congress
Serum Beta-(1,3)-D-Glucan as a Case-Finding Tool during an Outbreak of Pneumocystitis jirovecii Pneumonia in Abdominal Transplant Patients
J. Mittal, J. Mogollon, K. Cowman, P. Nori, V. Muggia, G. Minamoto, Y. Puius.
Division of Infectious Diseases, Montefiore Medical Center, Bronx, NY.
Background: Pneumocystis jirovecii pneumonia(PJP) in solid organ transplant (SOT) recipients carries significant morbidity and mortality. There is mounting evidence for ongoing risk of PJP in…
2018 American Transplant Congress
BK Nephropathy in Non-Kidney Transplant Patients, a Case Series and Systematic Review of the Literature
A. Shah,¹ V. Kumar,² B. Laskin,^2,3 D. Sawinski,^1,2 J. Hogan.^1,2
¹Division of Nephrology, Hospital of the University of Pennsylvania, Philadelphia; ²Perelman School of Medicine, Philadelphia; ³Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia.
Background: BK virus is highly seroprevalent but clinical disease typically occurs only in immunocompromised persons, most notably leading to significant morbidity in patients with kidney…
2018 American Transplant Congress
Technical Challenges in Living Donor Kidney Transplantation – Diagnosis and Solutions
R. Öllinger,¹ K. Alqasim,¹ F. Klein,¹ N. Raschzok,¹ P. Ritschl,¹ S. Chopra,¹ N. Otto,² T. Denecke,³ U. Gerlach,¹ M. Schmelzle,¹ P. Reinke,² J. Pratschke.¹
¹Department of Surgery, Charité, Berlin, Germany; ²Department of Nephrology, Charité, Berlin, Germany; ³Department of Radiology, Charité, Berlin, Germany.
IntroductionDue to organ scarcity living donation is becoming a major source of kidneys for transplantation. Besides medical contraindications, anatomy of the kidneys may be a…
2018 American Transplant Congress
Kidney Related Issues Leads the Medical Reasons to Exclude Potential Living Kidney Donors from Donation ; Prospective Study
H. Al-Eid, N. Sadaqah, I. Ibrahim, S. Aleid, A. Abdulbaki, S. Raza, I. Alahmadi, T. Ali, J. Brockman, D. Broring.
Kidney and Pancreas Transplantation, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Living kidney donors provide the best therapeutic option for patients with kidney failure going for kidney transplantation; however significant numbers of them are out for…
2018 American Transplant Congress
How Evaluation for Living Kidney Donation Saved My Life
M. Guthoff,¹ T. Mühlbacher,¹ S. Nadalin,² N. Heyne.¹
¹Dept. of Endocrinology and Diabetology, Angiology, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany; ²Dept. of General, Visceral and Transplant Surgery, University of Tübingen, Tübingen, Germany.
Purpose:In order to ensure eligibility for living kidney donation, donor candidates undergo a thorough medical evaluation. This evaluation process might reveal previously unknown medical conditions,…